Cargando…

人肺癌A549细胞系肿瘤干细胞的筛选和鉴定

BACKGROUND AND OBJECTIVE: Lung cancer stem cells are the root causes of lung cancer malignant phenotype and potential therapeutic target, the aim of this study is to isolate and characterize the cancer stem cells in the lung adenoearcinomas cell line A549, so as to provide an experimental basis for...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000669/
https://www.ncbi.nlm.nih.gov/pubmed/23945242
http://dx.doi.org/10.3779/j.issn.1009-3419.2013.08.02
_version_ 1783331807900467200
collection PubMed
description BACKGROUND AND OBJECTIVE: Lung cancer stem cells are the root causes of lung cancer malignant phenotype and potential therapeutic target, the aim of this study is to isolate and characterize the cancer stem cells in the lung adenoearcinomas cell line A549, so as to provide an experimental basis for further stem cell research. METHODS: The cancer stem cells were isolated from the lung adenoearcinomas cell line A549 using FACS. And the difference of colony formation, cell proliferation and tumorigenicity in vitro were also tested. The expression of CD133 and ABCG2 were evaluated by RTPCR and Western blot. RESULTS: The percentage of SP cells was 5.93% of A549 and 0.32% of A549 afer incubation with verapamil. The results showed that there were signifcantly higher expression of CD133 and ABCG2 on SP cells than that of non-SP cells. And the ability of colony formation, cell proliferation and tumorigenicity in SP cell group were remarkably higher than that in non-SP cell group. CONCLUSION: Our results suggested that the cancer stem cells with higher expression of CD133 and ABCG2 can be isolated from the lung adenoearcinomas cell line A549 using FACS and be used in the further research experiments.
format Online
Article
Text
id pubmed-6000669
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60006692018-07-06 人肺癌A549细胞系肿瘤干细胞的筛选和鉴定 Zhongguo Fei Ai Za Zhi 基础研究 BACKGROUND AND OBJECTIVE: Lung cancer stem cells are the root causes of lung cancer malignant phenotype and potential therapeutic target, the aim of this study is to isolate and characterize the cancer stem cells in the lung adenoearcinomas cell line A549, so as to provide an experimental basis for further stem cell research. METHODS: The cancer stem cells were isolated from the lung adenoearcinomas cell line A549 using FACS. And the difference of colony formation, cell proliferation and tumorigenicity in vitro were also tested. The expression of CD133 and ABCG2 were evaluated by RTPCR and Western blot. RESULTS: The percentage of SP cells was 5.93% of A549 and 0.32% of A549 afer incubation with verapamil. The results showed that there were signifcantly higher expression of CD133 and ABCG2 on SP cells than that of non-SP cells. And the ability of colony formation, cell proliferation and tumorigenicity in SP cell group were remarkably higher than that in non-SP cell group. CONCLUSION: Our results suggested that the cancer stem cells with higher expression of CD133 and ABCG2 can be isolated from the lung adenoearcinomas cell line A549 using FACS and be used in the further research experiments. 中国肺癌杂志编辑部 2013-08-20 /pmc/articles/PMC6000669/ /pubmed/23945242 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.08.02 Text en 版权所有©《中国肺癌杂志》编辑部2013 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 基础研究
人肺癌A549细胞系肿瘤干细胞的筛选和鉴定
title 人肺癌A549细胞系肿瘤干细胞的筛选和鉴定
title_full 人肺癌A549细胞系肿瘤干细胞的筛选和鉴定
title_fullStr 人肺癌A549细胞系肿瘤干细胞的筛选和鉴定
title_full_unstemmed 人肺癌A549细胞系肿瘤干细胞的筛选和鉴定
title_short 人肺癌A549细胞系肿瘤干细胞的筛选和鉴定
title_sort 人肺癌a549细胞系肿瘤干细胞的筛选和鉴定
topic 基础研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000669/
https://www.ncbi.nlm.nih.gov/pubmed/23945242
http://dx.doi.org/10.3779/j.issn.1009-3419.2013.08.02
work_keys_str_mv AT rénfèiáia549xìbāoxìzhǒngliúgànxìbāodeshāixuǎnhéjiàndìng
AT rénfèiáia549xìbāoxìzhǒngliúgànxìbāodeshāixuǎnhéjiàndìng
AT rénfèiáia549xìbāoxìzhǒngliúgànxìbāodeshāixuǎnhéjiàndìng
AT rénfèiáia549xìbāoxìzhǒngliúgànxìbāodeshāixuǎnhéjiàndìng
AT rénfèiáia549xìbāoxìzhǒngliúgànxìbāodeshāixuǎnhéjiàndìng
AT rénfèiáia549xìbāoxìzhǒngliúgànxìbāodeshāixuǎnhéjiàndìng